Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent - A systematic evaluation of triple oral therapy in a minority population

被引：21

作者：

Roy, R ^{[1
]}

Navar, M ^{[1
]}

Palomeno, G ^{[1
]}

Davidson, MB ^{[1
]}

机构：

[1] Charles R Drew Univ Med & Sci, Clin Trials Unit, Los Angeles, CA 90059 USA

来源：

DIABETES CARE | 2004年 / 27卷 / 07期

关键词：

D O I：

10.2337/diacare.27.7.1741

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1741 / 1742

页数：2

共 14 条

[1]

[Anonymous], 1995, Diabetes, V44, P1249

[2]

[Anonymous], 1995, DIABETES, V44, P968

[3]

[Anonymous], 1995, Br. Med. J, DOI DOI 10.1136/BMJ.310.6972.83

[4]

Bell David S H, 2002, Endocr Pract, V8, P271

[5]

BYRNE J, 2003, PRACT DIAB INT, V20, P58

[6] ONSET OF NIDDM OCCURS AT LEAST 4-7 YR BEFORE CLINICAL-DIAGNOSIS [J].

HARRIS, MI ;

KLEIN, R ;

WELBORN, TA ;

KNUIMAN, MW .

DIABETES CARE, 1992, 15 (07) :815-819

[7] Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients [J].

Kiayias, JA ;

Vlachou, ED ;

Theodosopoulou, E ;

Lakka-Papadodima, E .

DIABETES CARE, 2002, 25 (07) :1251-1252

[8] GLYCOSYLATED HEMOGLOBIN AND THE RISK OF MICROALBUMINURIA IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].

KROLEWSKI, AS ;

LAFFEL, LMB ;

KROLEWSKI, M ;

QUINN, M ;

WARRAM, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (19) :1251-1255

[9] INTENSIVE INSULIN THERAPY PREVENTS THE PROGRESSION OF DIABETIC MICROVASCULAR COMPLICATIONS IN JAPANESE PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS - A RANDOMIZED PROSPECTIVE 6-YEAR STUDY [J].

OHKUBO, Y ;

KISHIKAWA, H ;

ARAKI, E ;

MIYATA, T ;

ISAMI, S ;

MOTOYOSHI, S ;

KOJIMA, Y ;

FURUYOSHI, N ;

SHICHIRI, M .

DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 28 (02) :103-117

[10]

Ovalle F, 1998, Endocr Pract, V4, P146

← 1 2 →